2013 update on congenital heart disease, clinical cardiology, heart failure, and heart transplant.

Unidad de Cardiopatías Congénitas del Adolescente y Adulto Vall d'Hebron-Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: msubiranad@santpau.cat. Servicio de Cardiología, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Hospital Universitario de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain. Unidad de Cardiopatías Congénitas del Adulto, Hospital La Paz, Madrid, Spain. Unidad de Cardiopatías Familiares, Servicio de Cardiología, Hospital Son Llàtzer, Palma de Mallorca, Spain. Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco del Área del Corazón, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain. Unidad de Cardiología Pediátrica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Unidad de Insuficiencia Cardiaca, Servicio de Cardiología, Hospital Clínico Universitario San Carlos Madrid, Spain. Unidad de Insuficiencia Cardiaca y Cardiopatías Familiares, Hospital Universitario Virgen de la Victoria, Málaga, Spain.

Revista espanola de cardiologia (English ed.). 2014;(3):211-7

Abstract

This article presents the most relevant developments in 2013 in 3 key areas of cardiology: congenital heart disease, clinical cardiology, and heart failure and transplant. Within the area of congenital heart disease, we reviewed contributions related to sudden death in adult congenital heart disease, the importance of specific echocardiographic parameters in assessing the systemic right ventricle, problems in patients with repaired tetralogy of Fallot and indication for pulmonary valve replacement, and confirmation of the role of specific factors in the selection of candidates for Fontan surgery. The most recent publications in clinical cardiology include a study by a European working group on correct diagnostic work-up in cardiomyopathies, studies on the cost-effectiveness of percutaneous aortic valve implantation, a consensus document on the management of type B aortic dissection, and guidelines on aortic valve and ascending aortic disease. The most noteworthy developments in heart failure and transplantation include new American guidelines on heart failure, therapeutic advances in acute heart failure (serelaxin), the management of comorbidities such as iron deficiency, risk assessment using new biomarkers, and advances in ventricular assist devices.

Methodological quality

Publication Type : Review

Metadata